Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Agios Pharmaceuticals is a leading US biotechnology company dedicated to developing innovative therapies for rare diseases. The company focuses on researching cellular metabolism to deliver transformative medicines for individuals living with genetic blood disorders.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Agios Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Agios Pharmaceuticals last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -1.69 USD.
Agios Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.